MedTrace Logo

Assessment of the Capability of PulmoVista 500 to Continuously Monitor Changes of Ventilation Over Time

NCT03076983 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2019-11-27

Study results available
· View outcomes & findings →

Summary

The results of this study will help to define the capability and reliability of PulmoVista 500 to detect changes in both global and regional ventilation.

Conditions

  • Mechanical Ventilation
  • Single-lung Ventilation
  • ARDS
  • ALI - Acute Lung Injury
  • Weaning From Ventilator

Interventions

DEVICE

Lung Monitoring with EIT device (PulmoVista 500)

Patient's lungs will be monitored during clinical routine interventions with Dräger's EIT device (PulmoVista 500). No medical interventions to routine patient care required.

Sponsors & Collaborators

  • Technische Universität Dresden

    collaborator OTHER

  • Drägerwerk AG & Co. KGaA

    lead INDUSTRY

Principal Investigators

  • Peter M Spieth, Prof.Dr. med. · Universitätsklinikum Dresden

  • Oliver C Radke, Prof. Dr. · Klinikum Bremerhaven-Reinkenheide gGmbH

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-05-30
Primary Completion
2018-04-12
Completion
2018-04-12

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03076983 on ClinicalTrials.gov